Diabetic Retinopathy Screening, Trials and Treatment From an Equity Lens | Recording-Diabetic Retinopathy Screening, Trials and Treatment From an Equity Lens

Video Transcription

Video Summary

Dr. Kristen Wanyuwu from Yale University discussed the topic of health equity in diabetic retinopathy screening trials and treatment during a webinar. She highlighted the importance of addressing health disparities and social determinants of health in order to achieve health equity. Dr. Wanyuwu discussed the impact of racism, socioeconomic factors, and location on the prevalence and severity of diabetic retinopathy. She stressed the need for inclusive clinical trials and the importance of diversifying trial participants to ensure the generalizability of findings. Dr. Wanyuwu also emphasized the role of community engagement and collaboration in promoting health equity. She presented examples of local initiatives in New Haven and national efforts such as the Equitable Breakthroughs in Medicine Development (EQB Med) program and the discussion around reparations and historic injustices. Dr. Wanyuwu highlighted the importance of using AI and home monitoring devices to reduce the burden on patients and increase access to care. She emphasized the need to address barriers to follow-up care and develop proper infrastructure to support diverse clinical trials. Overall, Dr. Wanyuwu stressed the importance of building systems that prioritize health equity and engage communities in the pursuit of better health outcomes.

Keywords

Dr. Kristen Wanyuwu

Yale University

health equity

diabetic retinopathy

screening trials

social determinants of health

health disparities

clinical trials

community engagement